Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001578563-24-000391
Filing Date
2024-08-23
Accepted
2024-08-23 16:31:39
Documents
1
Effectiveness Date
2024-08-23
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 15159
  Complete submission text file 0001578563-24-000391.txt   16660
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-522335 | Film No.: 241236729
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)